Expertise in
9
conditions

Dr. Asim M. Roy

Sleep Medicine
Ohio Sleep Medicine And Neuroscience Institute Inc.
4975 Bradenton Ave, 
Dublin, OH 
Accepting New Patients
Expertise in
9
conditions
Ohio Sleep Medicine And Neuroscience Institute Inc.
4975 Bradenton Ave, 
Dublin, OH 

Overview

Asim Roy is a Sleep Medicine provider practicing medicine in Dublin, Ohio.

Dr. Roy is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Narcolepsy, Drowsiness, Restless Legs Syndrome, and Obstructive Sleep Apnea.

He is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 11 clinical trials. Dr. Roy is currently accepting new patients.

Specialties

Sleep Medicine

Licenses

Sleep Medicine in OH

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Ohio Sleep Medicine and Neuroscience Institute Inc.
4975 Bradenton Ave, Dublin, OH 43017

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Multicenter Study to Assess the Safety and Effectiveness of the Genio Dual-sided Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnea in Adults Subjects
A Multicenter Study to Assess the Safety and Effectiveness of the Genio Dual-sided Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnea in Adults Subjects
Enrollment Status: Active_not_recruiting
Publish Date: April 14, 2026
Intervention Type: Device
Study Phase: Not Applicable
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Open Label Study of Safety/Tolerability of Once Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy Patients That Have and Have Not Been Previously Maintained on Twice-nightly Sodium Oxybate IR
Enrollment Status: Completed
Publish Date: October 02, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A Multi-Center, Randomized, Double-Blind, Sham-Controlled Study to Evaluate the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS) - The RESTFUL Study
A Multi-Center, Randomized, Double-Blind, Sham-Controlled Study to Evaluate the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS) - The RESTFUL Study
Enrollment Status: Completed
Publish Date: October 08, 2024
Intervention Type: Device
Study Phase: Not Applicable
Exploratory Study Assessing the Response of Restless Legs Syndrome (RLS) Patients to Non-invasive Peripheral Nerve Stimulation (NPNS) During Opioid Medication Reduction
Exploratory Study Assessing the Response of Restless Legs Syndrome (RLS) Patients to Non-invasive Peripheral Nerve Stimulation (NPNS) During Opioid Medication Reduction
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
Inspire Home Study: Utilization of Home Monitoring During Therapy Optimization in Patients With an Inspire Upper Airway Stimulation System (Comparison of Home Sleep Testing vs. In-lab Polysomnography Testing)
Inspire Home Study: Utilization of Home Monitoring During Therapy Optimization in Patients With an Inspire Upper Airway Stimulation System (Comparison of Home Sleep Testing vs. In-lab Polysomnography Testing)
Enrollment Status: Completed
Publish Date: June 21, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 9 Less Clinical Trials

24 Total Publications

Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates: a plain language summary of publication.
Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates: a plain language summary of publication.
Journal: Expert review of neurotherapeutics
Published: May 21, 2026
Similar Doctors
Expertise in
11
conditions
Dr. Gautam K. Samadder
Sleep Medicine
Expertise in
11
conditions
Dr. Gautam K. Samadder
Sleep Medicine
Referral may be required

Office

99 N Brice Rd Ste 350, 
Columbus, OH 
 (16.1 miles away)
614-866-8200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gautam Samadder is a Sleep Medicine provider practicing medicine in Columbus, Ohio. Dr. Samadder is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Narcolepsy, Periodic Limb Movement Disorder, and Insomnia. Dr. Samadder is currently accepting new patients.

Expertise in
8
conditions
Dr. Susan D. Borchers
Sleep Medicine
Expertise in
8
conditions
Dr. Susan D. Borchers
Sleep Medicine
Referral may be required

The Millhon Clinic Inc

7630 Rivers Edge Dr, 
Columbus, OH 
 (5.7 miles away)
614-410-2494
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Susan Borchers is a Sleep Medicine provider practicing medicine in Columbus, Ohio. Dr. Borchers is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Drowsiness, Excessive Daytime Sleepiness, and Periodic Limb Movement Disorder. Dr. Borchers is currently accepting new patients.

Expertise in
9
conditions
Dr. Laurie A. Mooney
Sleep Medicine
Expertise in
9
conditions
Dr. Laurie A. Mooney
Sleep Medicine
Referral may be required

Sleep Medicine

1330 Coshocton Ave, 
Mount Vernon, OH 
 (42.0 miles away)
740-393-9915
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Laurie Mooney is a Sleep Medicine provider practicing medicine in Mount Vernon, Ohio. Dr. Mooney is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Central Sleep Apnea, Insomnia, and Drowsiness. Dr. Mooney is currently accepting new patients.

Frequently Asked Questions about Dr. Asim M. Roy

How do I make an appointment with Dr. Asim M. Roy?

You can book an appointment with Dr. Asim M. Roy by calling their office at 614-766-0773. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Asim M. Roy a top-rated expert for Narcolepsy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Asim M. Roy is classified as an Elite expert for Narcolepsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Asim M. Roy specialize in?

While Dr. Asim M. Roy is a Sleep Medicine, they have specific expertise in Narcolepsy, Drowsiness, and Restless Legs Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Sleep Medicine.

Does Dr. Asim M. Roy participate in research or clinical trials?

Yes. Dr. Asim M. Roy has published 24 articles and abstracts on conditions like Narcolepsy. You can view a list of Dr. Asim M. Roy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Asim M. Roy accept my insurance?

Dr. Asim M. Roy accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 614-766-0773 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Roy's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile